Rapid infusers are medical devices designe Newark, New Castle, USA, June 09, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global rapid infuser market was conducted by Growth Plus Reports in ...

The global rapid infuser market, valued at $796.9 million in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $1,109 million by 2031, as per a recent report ...

Durham-based 410 Medical has received up to nearly $2 million in U.S. military funding to develop two new versions of LifeFlow, its medical device for treating life-threatening low blood pressure ...

The global rapid infuser market share analysis is poised to achieve USD 1,209.4 million in sales by 2025, fueled by increasing trauma cases, a surge in emergency surgeries, and the growing demand for ...

Elevaris Medical Devices, a Contract Development and Manufacturing Organization (CDMO) for industry-leading, multi-national healthcare companies, global medical device manufacturers, and emerging ...

New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. Unlike traditional pumps that rely on specific setups and conditions for accurate delivery ...

YOKNEAM, Israel & SOUTHLAKE, Texas--(BUSINESS WIRE)--Rapid Medical™, a leading developer of advanced neurovascular devices, announced Japanese approval for its TIGERTRIEVER revascularization device.

Rapid is also zooming ahead in a new trial of the TigerTriever 13 device. The Distals study will track the system’s ability to remove clots from isolated, harder-to-reach regions of the brain.

Newark, New Castle, USA, June 09, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global rapid infuser market was conducted b. Tuesday, 02 January 2024 12:17 GMT. عربي. Log in ...

New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. SAN CLEMENTE, Calif. , April 7, 2025 /PRNewswire/ -- ICU Medical Inc .